An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Experimental Treatment Gaining Traction Online
Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these accounts directly for supplier links, while also receiving discount codes.
Thriving Commerce on Social Networks
Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share “before and after” images, injection guides and assertions of rapid UK delivery. Sellers market the drug there before directing buyers to WhatsApp for purchases.
Understanding The Experimental Drug
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Professionals Express Concerns
Nevertheless, doctors and chemists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals administering substances of unknown origin.
Some professionals said the popularity for retatrutide could be connected to the increasing cost of approved weight loss products such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for human use under the British medical regulations.
Several content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, advertising, and customer regulations, potentially leading to penalties, legal action or prison.
Service Reaction and Content Removal
Based on TikTok, the platform has taken down problematic content and banned related hashtags and search suggestions. The company said it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.
Digital Trading Activities
Investigations also found communities with up to nine thousand members selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly brings up channels with thousands of members, populated with photos of weight loss, positive reviews and step-by-step guides for preparing or injecting at residence.
Within moments of entering one group, a seller shared WhatsApp details, where the majority of purchases take place. The seller sent an guidebook and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about weight, medical conditions or past usage.
Item Details and Pricing
Within these groups, posts display black plastic packages with postal service stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When questioned how much time a pen should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for the messaging service said it actively monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting materials they cannot confirm. Even if the research behind this drug is valid, these digital products may not include what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service connected the surge in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.
Her staff has already seen individuals harmed by personal administration from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company investigational substance not yet authorized … may expose patients to potentially serious medical dangers”.
